Skip to content
Home/Companies/Biotech/Samsara Therapeutics
Samsara Therapeutics

Samsara Therapeutics

Biotech·United Kingdom·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Samsara Therapeutics?

Samsara Therapeutics is a British Biotech company, currently owned by Apollo Health Ventures since 2019.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Apollo Health Ventures
Investor
Apollo Health Ventures
Apollo Health Ventures Fund I · 2018 · Evergreen

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive
Websitesamsaratherapeutics.com

More from Apollo Health Ventures Fund I

Other portfolio companies in the same fund.

Refoxy Pharmaceuticals
Refoxy Pharmaceuticals
Active
BiotechGermany· 2020
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals
Active
BiotechUS· 2019

More Apollo Health Ventures portfolio companies

From the same investor, across funds.

BioNYRA Pharma
Active
BiotechFrance· 2026
Cognito Therapeutics
Active
United States· 2026
Scripta Therapeutics
Active
BiotechUnited Kingdom· 2025
Therini Bio
Therini Bio
Active
BiotechUS· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Auron Therapeutics
Auron Therapeutics
Active
BiotechUS· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Samsara Therapeutics?

Samsara Therapeutics is currently owned by Apollo Health Ventures, through Apollo Health Ventures Fund I, since 2019.

When did Apollo Health Ventures acquire Samsara Therapeutics?

Apollo Health Ventures acquired Samsara Therapeutics in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue